Review Date: October 2024
- Patients
- Benign disease services
- Ledderhose disease
Introduction
Ledderhose disease
Radiation therapy for Ledderhose disease
Radiation therapy may help to treat symptoms and help prevent worsening of Ledderhose disease.1,2
What is Ledderhose disease?
Chapter 01
What is Ledderhose disease?
Ledderhose disease, also called plantar fibromatosis or Dupuytren’s of the foot, is a benign thickening of the connective tissue (fascia) in the sole of the foot.2-4
For most people, the main symptom is a slow-growing lump in the arch of the foot.2,3 It typically starts as a small lump and may not affect quality-of-life for some time.2,3 However, over time, the nodule may grow larger and can start to cause tenderness and pain, especially when standing or walking.2-4
It is generally seen in middle-aged or elderly people and occurs more frequently in men than women.1,3 Some people can experience symptoms in both feet.1,3,4
Make an enquiry
To learn more about radiation therapy for Ledderhose disease, make an enquiry. Please note: A referral from a GP or specialist is needed for an initial assessment by a radiation oncologist.
What causes Ledderhose disease?
Chapter 02
What causes Ledderhose disease?
The main cause of Ledderhose disease remains uncertain.1 There are several associated conditions, such as Dupuytren’s Disease and Peyronie’s Disease.
How is Ledderhose disease treated?
Chapter 03
How is Ledderhose disease treated?
You should discuss treatment options with your referring doctor or specialist. Treatment recomendations depend on a number of factors including disease severity.2,3 The primary aim of treatment is to regain quality of life, which includes increased mobility, pain reduction and return to normal function where possible.2 Treatment options can include:2,3
- Steroid injections
- Orthodics
- Radiation therapy
- Extracorporeal shock wave therapy
- Surgery
Radiation therapy for Leddderhose disease
Chapter 04
Radiation therapy for Leddderhose disease
Assessment
An initial assessment and discussion is important to help understand the uncertainties and alternative treatment options.
At the assessment, your specialist will discuss whether radiotherapy might be helpful for your condition, as well any as side-effects you may experience.
Note: You will need a referral from a GP or specialist for an assessment.
Treatment
Radiation therapy is one treatment option for Ledderhouse disease.2 When used, its purpose is to try and prevent the worsening of symptoms as well as improve mobility and reduce pain.2
Research has shown that radiation therapy for Ledderhose will see 74% of people achieve pain relief.2 Your doctor can offer more specific details around how the therapy works, how the radiation is delivered and how long it takes, as well as any risks or potential side-effects.
Following the completion of radiation therapy treatment, please speak to your doctor directly regarding any concerns or side-effects that you may experience.
Make an enquiry
To learn more about radiation therapy for Ledderhose disease, make an enquiry. Please note: A referral from a GP or specialist is needed for an initial assessment by a radiation oncologist.
Content reviewed by
Professor Jarad Martin
MBChB BSc PhD DMed, FRANZCR GAustMS
Radiation Oncologist
Maitland (Oncology) +1
Find a centre near you
Read next
Condition
Dupuytren’s disease
Dupuytren’s disease is a benign condition that causes excessive scar tissue within the fibrous fascia beneath the skin of the palm of the hand.
Condition
Keloid scars
A keloid scar is a benign, overgrown lump that can sometimes develop when a wound heals, or even after minor skin damage such as acne or ear piercing.
Condition
Plantar fasciitis
Plantar fasciitis is a very common repetitive strain condition affecting around 10% of the population at some point in their lives, more commonly women.
- Meyers, AL and Marquart MJ. National Library of Medicine. StatPearls Publishing LLC [Internet]. Plantar Fibromatosis. Treasure island (FL). Last Update: June 2022 [Cited July 2023]. Access from: https://www.ncbi.nlm.nih.gov
- De Hann, A., et al. Radiother Oncol. 2023 Aug;185:109718.
- Young, JR, et al. Orthop Res Rev 2018 Dec 17;11:1-7
- Akdag, O et al. Surg J (N Y). 2016 Jul; 2(3): e102–e104.
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.
You are leaving our website
You are now leaving our website. GenesisCare do not control this content and therefore are not responsible for its accuracy or reliability.
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.